Scancell Holdings PLC (SCLP)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
9.00p
Buy
10.00p
-0.25p (-2.56%)
Scancell Holdings PLC is a biopharmaceutical company focused on the cancer therapeutics market. The company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer.
Prices updated at 29 May 2025, 15:54 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
10.00p - 9.50p | |
19.75p - 7.26p | |
- | |
101.09m | |
- | |
30,000 | |
160,390 | |
- | |
896,234.53 | |
1.42 | |
928.98m | |
GB00B63D3314 | |
-0.02 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.